WAVE Life Sciences Ltd Stock
Price
Target price
€6.55
€6.55
2.340%
0.15
2.340%
€17.31
08.12.25 / Stuttgart Stock Exchange
WKN: A1436W / Symbol: WVE / Name: WAVE Life / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
WAVE Life Sciences Ltd Stock
There is an upward development for WAVE Life Sciences Ltd compared to yesterday, with an increase of €0.15 (2.340%).
Currently there is a rather positive sentiment for WAVE Life Sciences Ltd with 15 Buy predictions and 3 Sell predictions.
With a target price of 17 € there is potential for a 159.54% increase which would mean more than doubling the current price of 6.55 € for WAVE Life Sciences Ltd.
So far the community has only identified positive things for WAVE Life Sciences Ltd stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | 2.340% | 3.968% | -1.504% | -51.481% | -46.311% | 78.766% | -4.380% |
| Intellia Therapeutics Inc | -2.110% | 12.069% | -1.046% | -41.587% | -28.429% | -77.605% | -79.170% |
| Chromadex Corp | -2.700% | -4.425% | -3.571% | -12.195% | 4.854% | 248.500% | 30.435% |
| Polynovo Ltd | 0.760% | 2.326% | 1.538% | -49.231% | -45.455% | -45.455% | -71.053% |
Comments
WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Wedbush from $18.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $16.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
